CAR-T Disease Outlook [2017] – PharmiWeb.com (press release)
|
CAR–T Disease Outlook [2017]
PharmiWeb.com (press release) Anti-CD19 CAR–T cell therapies have demonstrated unprecedented response rates across patient subgroups of acute lymphocytic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) with high unmet needs. How will the impressive efficacy and safety of … |
